• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The role of multiparametric MRI in predicting lymphovascular invasion in breast cancer patients.多参数 MRI 在预测乳腺癌患者淋巴管血管侵犯中的作用。
Future Oncol. 2024;20(35):2747-2756. doi: 10.1080/14796694.2024.2396273. Epub 2024 Sep 13.
2
MRI Radiomics-Based Machine Learning to Predict Lymphovascular Invasion of HER2-Positive Breast Cancer.基于MRI影像组学的机器学习预测HER2阳性乳腺癌的淋巴管侵犯
J Imaging Inform Med. 2024 Nov 13. doi: 10.1007/s10278-024-01329-x.
3
A 3D deep learning model based on MRI for predicting lymphovascular invasion in rectal cancer.一种基于磁共振成像(MRI)的3D深度学习模型,用于预测直肠癌中的淋巴管侵犯。
Med Phys. 2025 Jul;52(7):e17882. doi: 10.1002/mp.17882. Epub 2025 May 20.
4
A novel MRI-based radiomics for preoperative prediction of lymphovascular invasion in rectal cancer.一种基于磁共振成像的新型影像组学用于直肠癌术前预测淋巴管侵犯
Abdom Radiol (NY). 2025 Jan 12. doi: 10.1007/s00261-025-04800-7.
5
Integrating Peritumoral and Intratumoral Radiomics with Deep Learning for Preoperative Prediction of Lymphovascular Invasion in Invasive Breast Cancer Using DCE-MRI.整合瘤周和瘤内放射组学与深度学习用于基于动态对比增强磁共振成像术前预测浸润性乳腺癌的淋巴管侵犯
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251374945. doi: 10.1177/15330338251374945. Epub 2025 Sep 3.
6
An Integrative Clinical and Intra- and Peritumoral MRI Radiomics Nomogram for the Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer.一种用于术前预测直肠癌淋巴管侵犯的综合临床及瘤内和瘤周MRI影像组学列线图
Acad Radiol. 2025 Mar 4. doi: 10.1016/j.acra.2025.02.019.
7
The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer.原发性可手术乳腺癌中淋巴管和血管侵犯对预测生存的作用及检测方法。
Crit Rev Oncol Hematol. 2014 Feb;89(2):231-41. doi: 10.1016/j.critrevonc.2013.08.014. Epub 2013 Sep 12.
8
Multi-parameter MRI deep learning model for lymphovascular invasion assessment in invasive breast ductal carcinoma: A multicenter, retrospective study.用于浸润性乳腺导管癌淋巴管侵犯评估的多参数MRI深度学习模型:一项多中心回顾性研究。
Clin Radiol. 2025 Sep;88:107002. doi: 10.1016/j.crad.2025.107002. Epub 2025 Jun 25.
9
Prediction of lymphovascular invasion in invasive breast cancer via intratumoral and peritumoral multiparametric magnetic resonance imaging machine learning-based radiomics with Shapley additive explanations interpretability analysis.通过基于机器学习的肿瘤内和肿瘤周围多参数磁共振成像放射组学及Shapley加性解释可解释性分析预测浸润性乳腺癌中的淋巴管侵犯
Quant Imaging Med Surg. 2025 Sep 1;15(9):7833-7846. doi: 10.21037/qims-2024-2685. Epub 2025 Aug 18.
10
Establishment of an interpretable MRI radiomics-based machine learning model capable of predicting axillary lymph node metastasis in invasive breast cancer.建立一种基于可解释性磁共振成像放射组学的机器学习模型,该模型能够预测浸润性乳腺癌腋窝淋巴结转移。
Sci Rep. 2025 Jul 18;15(1):26030. doi: 10.1038/s41598-025-10818-0.

本文引用的文献

1
To Dissect or Not to Dissect? The Surgeon's Perspective on the Prediction of Greater Than or Equal to 4 Axillary Lymph Node Metastasis in Early-Stage Breast Cancer: A Comparative Analysis of the Per-Protocol Population of the SINODAR-ONE Clinical Trial.剖析与否?外科医生对早期乳腺癌中≥4枚腋窝淋巴结转移预测的观点:SINODAR-ONE临床试验符合方案人群的比较分析
Ann Surg Open. 2024 Mar 12;5(1):e405. doi: 10.1097/AS9.0000000000000405. eCollection 2024 Mar.
2
Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy.第72位密码子的基因多态性作为新辅助化疗反应的预测指标
Breast Care (Basel). 2024 Apr;19(2):96-105. doi: 10.1159/000536115. Epub 2024 Jan 8.
3
Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting.RIBBIT研究的最终结果:一项随机III期研究,旨在评估一线接受瑞博西尼联合内分泌治疗或联合或不联合贝伐单抗的化疗的激素受体阳性、HER2阴性转移性乳腺癌患者的疗效和生活质量。
Breast Care (Basel). 2024 Feb;19(1):49-61. doi: 10.1159/000535135. Epub 2023 Dec 20.
4
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy.转移性乳腺癌化疗患者电子患者报告结局监测系统的初步试验。
Breast Cancer. 2024 Mar;31(2):283-294. doi: 10.1007/s12282-023-01537-3. Epub 2024 Jan 4.
5
Diagnostic accuracy of the breast MRI Kaiser score in suspected architectural distortions and its comparison with mammography.乳腺 MRI Kaiser 评分对疑似结构扭曲的诊断准确性及其与乳腺 X 线摄影的比较。
Sci Rep. 2024 Jan 3;14(1):447. doi: 10.1038/s41598-023-50798-7.
6
The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2022 edition.日本乳腺癌学会 2022 年版乳腺癌流行病学和预防临床实践指南。
Breast Cancer. 2024 Mar;31(2):166-178. doi: 10.1007/s12282-023-01531-9. Epub 2023 Dec 26.
7
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre.放射性诱发的乳腺血管肉瘤:区域治疗中心的回顾性分析
Breast Cancer. 2024 Mar;31(2):272-282. doi: 10.1007/s12282-023-01535-5. Epub 2023 Dec 26.
8
Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.乳腺癌非肿块增强区的动态对比增强 MRI 特征与 Ki-67 阳性表达的表观扩散系数的相关性。
Sci Rep. 2023 Dec 5;13(1):21451. doi: 10.1038/s41598-023-48445-2.
9
Multiparametric Approach to Breast Cancer With Emphasis on Magnetic Resonance Imaging in the Era of Personalized Breast Cancer Treatment.多参数方法在乳腺癌诊治中的应用——个体化乳腺癌治疗时代的磁共振成像重点
Invest Radiol. 2024 Jan 1;59(1):26-37. doi: 10.1097/RLI.0000000000001044. Epub 2023 Nov 22.
10
Characterization of Expression and Function of the Formins FHOD1, INF2, and DAAM1 in HER2-Positive Breast Cancer.人表皮生长因子受体2阳性乳腺癌中formin家族蛋白FHOD1、INF2和DAAM1的表达及功能特征
J Breast Cancer. 2023 Dec;26(6):525-543. doi: 10.4048/jbc.2023.26.e47. Epub 2023 Nov 17.

多参数 MRI 在预测乳腺癌患者淋巴管血管侵犯中的作用。

The role of multiparametric MRI in predicting lymphovascular invasion in breast cancer patients.

机构信息

Medical Image Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.

The Third of Clinical Medicine, Southern Medical University, Shenzhen, China.

出版信息

Future Oncol. 2024;20(35):2747-2756. doi: 10.1080/14796694.2024.2396273. Epub 2024 Sep 13.

DOI:10.1080/14796694.2024.2396273
PMID:39268927
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11572066/
Abstract

This study aims to investigate the efficacy of multifactorial MRI in diagnosing breast cancer, specifically in the context of predicting lymphovascular invasion (LVI). The patients were stratified into two groups: the primary group (100 patients) and the validation group (100 patients), based on essential characteristics. Multifactorial MRI, encompassing tumor size evaluation, diffusion coefficient assessment and dynamic contrast enhancement, was employed for patient examination. Statistically significant differences were observed in tumor size, diffusion coefficient and dynamic contrast enhancement between groups with LVI (LVI+) and those without (LVI-). Key parameters were identified for predicting the degree of invasion. The results affirm the effectiveness of multifactorial MRI in forecasting LVI.

摘要

本研究旨在探究多因素 MRI 在诊断乳腺癌方面的功效,特别是在预测淋巴血管侵犯(LVI)方面。患者根据基本特征分为两组:主要组(100 例)和验证组(100 例)。多因素 MRI 用于患者检查,包括肿瘤大小评估、扩散系数评估和动态对比增强。在有 LVI(LVI+)和没有 LVI(LVI-)的组之间,肿瘤大小、扩散系数和动态对比增强方面存在统计学显著差异。确定了预测侵犯程度的关键参数。结果证实了多因素 MRI 在预测 LVI 方面的有效性。